A new study suggests that two widely used Type 2 diabetes medications—GLP-1 receptor agonists and SGLT2 inhibitors—may help reduce the risk of Alzheimer’s disease and related dementias.

A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...

A study led by researchers in the University of Florida College of Pharmacy has found that a pair of popular glucose-lowering medications may have protective effects against the development of ...

Middle-aged folks and seniors whose weed use lands them in the hospital are at higher risk for developing dementia within a ...

This region’s first centre, which is one-of-its-kind, will offer novel blood-based screening starting at age 40, enabling early intervention and significantly enhancing patient outcomes.

At her mother’s home in Illinois, Tracy Balhan flips through photos of her dad, Bill Speer. In one picture, he’s smiling in ...

Professor will ‘co-design and test a culturally relevant intervention to meet these unique needs’ of LGBT caregivers.